Impact Factor
0.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.00
0 total citations
h5-index
2
h5 depth signal
Cited share
0.0%
0 of 0
Total citations
0
Citation footprint
Metric signal
0.00
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Citing Geographic Demographics
China
24
Citing Fields of Research
Lung Cancer
4
Breast Cancer
4
Digestive Disorders
3
Oncology
3
Musculoskeletal & Nerve Cancer
2
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
127
Articles tracked across the journal lifetime
Indexed publication set
0
0 cited publications
Last 12 months
0
0.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
China
24 citing publications
Leading citing field
Lung Cancer
4 citing publications
Latest tracked publication
23 November 2022
10 recent records available
Coverage & Indexing History
1979-
1979-
Active Coverage
Research Focus & Classification
Issuing & Sponsoring Bodies
Contributor
China
Contributor
Zhonghua zhong liu za zhi bian ji wei yuan hui
Contributor
Zhonghua yi xue hui (China : 1949- )
Broad Categories
Neoplasms
MeSH Descriptors
Medical Oncology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.3760/cma.j.cn112152-20210611-00445
Open DOI
[A case of metastatic von Hippel Lindau-pancreatic neuroendocrine tumor].
02
DOI 10.3760/cma.j.cn112152-20200305-00172
Open DOI
[Ultrasonographic features and clinical pathological of liver metastasis in patients with melanoma].
Objective: To investigate the ultrasonographic features and clinical pathological of liver metastasis in patients with melanoma. Methods: Thirteen patients with liver metastasis from melanoma treated in Tianjin Medical University Cancer ...
03
DOI 10.3760/cma.j.cn112152-20200525-00485
Open DOI
[Pretreatment evaluation of 18F-FDG PET-CT in extranodal NK/T-cell lymphoma].
Objective: To investigate the clinical value of pretreatment 18F-fluorodeoxy glucose positron emission tomography/computed tomography (18F-FDG PET-CT) in extranodal NK/T-cell lymphoma. Methods: Eighty-one patients with pathologically con...
04
DOI 10.3760/cma.j.cn112152-20200803-00704
Open DOI
[Expression comparison and clinical significance of PD-L1 (22C3) and PD-L1 (SP142) in triple negative breast cancer].
Objective: To investigate the expression of programmed death ligand-1 (PD-L1, SP142) and PD-L1 (22C3) in triple-negative breast cancer (TNBC), and analyze their correlation with the clinicopathological factors and prognosis. Methods: The...
05
DOI 10.3760/cma.j.cn112152-20190613-00380
Open DOI
[Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes].
Objective: To screen the different expressed genes between osteosarcoma and normal osteoblasts, and find the key genes for the occurrence and development of osteosarcoma. Methods: The gene expression dataset GSE33382 of normal osteoblast...
06
DOI 10.3760/cma.j.cn112152-20200222-00116
Open DOI
[Effects of LINC00839 targeting miR-3666 on proliferation, migration and invasion of hepatocellular carcinoma cells].
Objective: To investigate the effects of lncRNA LINC00839 on the proliferation, migration and invasion of hepatocellular carcinoma cells and its mechanism. Methods: Real-time quantitative polymerase chain reaction (RT-qPCR) was used to d...
07
DOI 10.3760/cma.j.cn112152-20200109-00016
Open DOI
[Analysis of the clinical effects and outcome of patients with double-hit high-risk multiple myeloma].
Objective: To compare the clinical features, clinical efficacy, and prognosis of patients with double-hit and non-double-hit high-risk multiple myeloma (MM) and explored the clinical significance of high-risk cell karyotype in MM develop...
08
DOI 10.3760/cma.j.cn112152-20210720-00528
Open DOI
[Expert consensus on graded management of antineoplastic drugs].
The standardized diagnosis and treatment of tumor and the rational use of antineoplastic drugs are not only the central issue of the government and society, but also the difficulty of medical quality control. In order to implement "the A...
09
DOI 10.3760/cma.j.cn112152-20200623-00591
Open DOI
[Immune evasion mechanism and its clinical application value in Hodgkin's lymphoma].
Hodgkin's lymphoma (HL) is a unique malignancy in which rare malignant Hodgkin and Reed-Sternberg (HRS) cells are scattered in the inflammatory cell rich microenvironment. This extensive but ineffective inflammatory cell infiltrate indic...
10
DOI 10.3760/cma.j.cn112152-20200116-00043
Open DOI
[Expression of melanoma-associated antigen-C2 in breast cancers and mechanism].
Objective: To analyze the expression pattern, mechanism and clinical significance of melanoma-associated antigen-C2 (MAGE-C2) in tumor-free breast specimens, breast benign disease specimens and breast cancer specimens. Methods: Reverse t...
Bibliographical & Catalog Notes
Also issued online.
Articles in Chinese; table of contents in Chinese and English; some abstracts in English.
Issued by Wei sheng bu Zhong liu fang zhi yan jiu ban gong shi and Zhonghua zhong liu za zhi bian ji wei yuan hui.